Manuscripts

Search by keyword, year, or author name.

Showing 1595 manuscripts.

Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial

Nancy Radcliffe Reynolds, Ph.D., Marcia A. Testa, M.P.H., Ph.D., Max Su, Sc.D., Margaret A. Chesney, Ph.D., Judith Neidig, R.N., Ph.D., Ian Frank, M.D., Scott R. Smith, Ph.D., Jeannette Ickovics, Ph.D., Gregory K. Robbins, M.D., M.P.H. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes. 2008 Jan 01; 47(1):62-8.

Year

2008

Journal

Journal of Acquired Immune Deficiency Syndromes

Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV

Ann C. Collier, M.D., Camlin Tierney, Ph.D., Gerald F. Downey, M.Sc., Susan H. Eshleman, M.D., PH.D., Angela D.M. Kashuba, Pharm.D., Karin L. Klingman, M.D., Emanuel N. Vergis, M.D., M.P.H., Gary E. Pakes, Pharm.D., James F. Rooney, M.D., Alex R. Rinehart, Ph.D., John W. Mellors, M.D. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. HIV Clinical Trials. 2008 Mar 01; 9(2):91-102.

Year

2008

Journal

HIV Clinical Trials

Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186

John G. Gerber, M.D., Doug Kitch, M.S., Carl J. Fichtenbaum, M.D., Robert Zackin, Sc.D., Stephannie Charles, B.A., Evelyn Hogg, B.A., Edward P. Acosta, Pharm.D., Elizabeth Connick, M.D., David Alain Wohl, M.D., Erna Milu Kojic, M.D., Constance A. Benson, M.D., Judith A. Aberg, M.D. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. Journal of Acquired Immune Deficiency Syndromes. 2008 Apr 01; 47(4):459-66. PMCID: PMC2788607.

Year

2008

Journal

Journal of Acquired Immune Deficiency Syndromes

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

Lisa M. Demeter, M.D., Victor DeGruttola, Sc.D., Stephanie Lustgarten, M.S., Daniel Bettendorf, M.S., Margaret A. Fischl, M.D., Susan H. Eshleman, M.D., PH.D., William Spreen, Pharm.D., Bach-Yen Nguyen, M.D., Christine E. Koval, Joseph J. Eron, Jr., M.D., Scott M. Hammer, M.D., Kathleen E. Squires, M.D. Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. HIV Clinical Trials. 2008 Jan 01; 9(1):11-25. PMCID: PMC2821073.

Year

2008

Journal

HIV Clinical Trials

Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021.

Adriana Weinberg, M.D., Ruth E. Dickover, Ph.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Julie A. Patterson, B.S., Howard Gutzman, B.S., William T. Shearer, M.D., Ph.D., Rebecca S. Gelman, Ph.D., Mobeen H. Rathore, M.D., Ross E. McKinney, Jr., M.D. Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021. AIDS and Public Policy Journal. 2008 Nov 12; 22(17):2267-77. PMID: 18981766; PMCID: PMC2748303.

Year

2008

Journal

AIDS and Public Policy Journal

Study

P1021

Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.

Caroline J. Chantry, M.D., Michael Hughes, Ph.D., Carmelita Alvero, Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., William A. Meyer, III, Ph.D., Janice Hodge, R.N., B.S., Peggy R. Borum, Ph.D., John ( Jack ) Moye, Jr., M.D. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy. Pediatrics. 2008 Jul 01; 122(e):129-38. PMID: 18519448; PMCID: PMC2782494.

Year

2008

Journal

Pediatrics

Study

P1010

Nevirapine concentrations in newborns receiving an extended prophylactic regimen.

Mark Mirochnick, M.D., Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Jose Henrique Pilotto, M.D., Jorge Pinto, M.D., D.Sc., Eleanor Jimenez, M.D., F.A.A.P., Valdilea V. Santos, M.D., Ph.D., Teresa Parsons, Ph.D., Heather D. Watts, M.D., John ( Jack ) Moye, Jr., M.D., Lynne M. Mofenson, M.D., F.A.A.P., Margaret Camarca, M.P.H., Yvonne J. Bryson, M.D. Nevirapine concentrations in newborns receiving an extended prophylactic regimen. Journal of Acquired Immune Deficiency Syndromes. 2008 Mar 01; 47(3):334-7. PMID: 18398973.

Year

2008

Journal

Journal of Acquired Immune Deficiency Syndromes

Study

P1043/HPTN 040

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.

Myron Levin, M.D., Lin-Ye Song, Ph.D., Terence Fenton, Ed.D., Sharon Appelbaum Nachman, M.D., Julie A. Patterson, B.S., Robert Walker, M.D., George Kemble, Ph.D., Maria Allende, M.D., Micki Hultquist, Tingting Yi, Barbara Nowak, B.A., Adriana Weinberg, M.D. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine. 2008 Aug 05; 26(33):4210-7. PMID: 18597900; PMCID: PMC2615200.

Year

2008

Journal

Vaccine

Study

P1057

Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia

William Borkowsky, M.D., Ram Yogev, M.D., Petronella Muresan, M.S., Lisa M. Frenkel, M.D., Terence Fenton, Ed.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Paul Harding, M.S., Nina Ellis, B.S., Barbara E. Heckman, B.S. Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia. Vaccine. 2008 Jun 19; 26(24):3086-9.

Year

2008

Journal

Vaccine

Study

P1015